ARID1A and biliary tract cancer: Some study found that a novel deletion of MUC17 at 7q22.1 affected prognosis of biliary tract cancer patients which have negative effects on mutated genes including TP53, KRAS, SMAD4, NF1, ARID1A, PBRM1, and ATR30.